Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas-Reference-Cited by-同舟云学术

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

Published:2012-07-23 Issue:25 Volume:32 Page:3091-3100
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Wang P,Dong Q,Zhang C,Kuan P-F,Liu Y,Jeck W R,Andersen J B,Jiang W,Savich G L,Tan T-X,Auman J T,Hoskins J M,Misher A D,Moser C D,Yourstone S M,Kim J W,Cibulskis K,Getz G,Hunt H V,Thorgeirsson S S,Roberts L R,Ye D,Guan K-L,Xiong Y,Qin L-X,Chiang D Y

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2012315.pdf

Reference46 articles.

1. Yan H, Parsons DW, Jin GL, McLendon R, Rasheed BA, Yuan WS et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765–773.

2. Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrozek K, Margeson D et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol 2010; 28: 2348–2355.

3. Amary MF, Bacsi K, Maggiani F, Damato S, Halai D, Berisha F et al. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 2011; 224: 334–343.

4. Shibata T, Kokubu A, Miyamoto M, Sasajima Y, Yamazaki N . Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. Am J Pathol 2011; 178: 1395–1402.

5. Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 2011; 43: 1262–1265.

Cited by 329 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and Sex Differences in Genomic Profiling of Intrahepatic Cholangiocarcinoma;Annals of Surgical Oncology;2024-09-09

2. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

3. Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches;Cancers;2024-08-20

4. A perioperative study of Safusidenib in patients with IDH1 -mutated glioma;Future Oncology;2024-08-14

5. Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives;Cancers;2024-08-02